ContraFect

ContraFect EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of ContraFect (CFRXQ) as of Oct 20, 2026 is -282.83 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was -70.81 % — a change of 299.45% (lower).

EBIT/Assets

-282.83 %

YoY

299.45%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of ContraFect is 2022 -282.83 % . Operating Income to Assets Ratio (EBIT/Assets) of ContraFect was 2021 -70.81 % . It decreases by 299.45% lower compared to the previous year.

The ContraFect EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2015
-69.91 USD
Jan 1, 2016
-89.13 USD
Jan 1, 2017
-52.92 USD
Jan 1, 2018
-94.68 USD
Jan 1, 2019
-79.61 USD
Jan 1, 2020
-66.98 USD
Jan 1, 2021
-70.81 USD
Jan 1, 2022
-282.83 USD
The ContraFect EBIT/Assets history
YEAREBIT/AssetsYoY
-282.83 %+299.45%
-70.81 %+5.71%
-66.98 %-15.86%
-79.61 %-15.92%
-94.68 %+78.91%
-52.92 %-40.63%
-89.13 %+27.49%
-69.91 %+24.02%
-56.37 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ContraFect Stock analysis

What does ContraFect do? ContraFect Corp, based in Yonkers, New York, is a clinical-stage biotechnology company focused on developing direct lytic agents (DLAs) such as lysins and amurin peptides to treat life-threatening antibiotic-resistant infections. The company, listed in 2014, employs 23 people and is advancing its lead candidate exebacase (CF-301) for MRSA bloodstream infections and chronic prosthetic joint infections, alongside CF-370 targeting gram-negative bacteria. ContraFect is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ContraFect stock

Operating Income to Assets Ratio (EBIT/Assets) of ContraFect is -282.83 % in 2022.

Operating Income to Assets Ratio (EBIT/Assets) of ContraFect changed from -70.81 % to -282.83 %, representing a 299.45% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) ContraFect since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s ContraFect with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — ContraFect

All Key Metrics — ContraFect